Call to Expand Access to and Confidence in COVID-19 Vaccines More Widely

CEPI (Coalition for Epidemic Preparedness Innovations) is a global partnership between public, private, philanthropic, and civil organisations to develop vaccines to stop future epidemics.

This Call for Proposals is to support one or several clinical trials with the aim of rapidly expanding access to and confidence in COVID-19 vaccines by:

1. Generating clinical evidence in special/sub-populations/age groups.

2. Addressing clinical development gaps.

Clinical trials which expand access and capacity in low and middle income countries (LMICs) are particularly encouraged.

Each proposed clinical trial will be evaluated against knowledge gaps (pre- or post-licensure) related to the specific COVID-19 vaccine/platform technology, as well as in the context of the COVID-19 pandemic. The funding is intended for complementary clinical trials which:

Represent amendments or extensions to ongoing trials.

Are new clinical trials which will be able to start expeditiously after contracting.

Vaccine developers, individual organisations, and consortia are eligible to apply. Applicants must be legal entities, or consortia comprised of legal entities. The call is open worldwide.

CEPI will make available up to US $140 million in funding.

Expressions of Interest (EOIs) should be submitted by the deadline of 28 May 2021.

EOIs will be reviewed on a rolling basis, as they are received. The call may be extended or amended depending on programmatic need and may be closed earlier in case the budget limit has been reached.

More information about this research funding opportunity and the application process is available on the RESEARCHconnect funding information platform. RESEARCHconnect provides up-to-the minute content, insight and analysis on research funding news and policy. To find out more about how RESEARCHconnect can keep you in the know, and subscription fees, contact us today.